These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 35793567)

  • 1. The modifying effect of the serum-to-dialysate potassium gradient on the cardiovascular safety of SSRIs in the hemodialysis population: a pharmacoepidemiologic study.
    Assimon MM; Pun PH; Al-Khatib SM; Brookhart MA; Gaynes BN; Winkelmayer WC; Flythe JE
    Nephrol Dial Transplant; 2022 Oct; 37(11):2241-2252. PubMed ID: 35793567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Cardiac Safety of Selective Serotonin Reuptake Inhibitors among Individuals Receiving Maintenance Hemodialysis.
    Assimon MM; Brookhart MA; Flythe JE
    J Am Soc Nephrol; 2019 Apr; 30(4):611-623. PubMed ID: 30885935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton pump inhibitors may enhance the risk of citalopram- and escitalopram-associated sudden cardiac death among patients receiving hemodialysis.
    Assimon MM; Pun PH; Al-Khatib SM; Brookhart MA; Gaynes BN; Winkelmayer WC; Flythe JE
    Pharmacoepidemiol Drug Saf; 2022 Jun; 31(6):670-679. PubMed ID: 35285107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. QT-Prolonging Antibiotics, Serum-to-Dialysate Potassium Gradient, and Risk of Sudden Cardiac Death Among Patients Receiving Maintenance Hemodialysis.
    Pun PH; Assimon MM; Wang L; Al-Khatib SM; Brookhart MA; Weber DJ; Winkelmayer WC; Flythe JE
    Kidney Med; 2023 May; 5(5):100618. PubMed ID: 37113163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective serotonin reuptake inhibitors and the risk of type 2 diabetes mellitus in youths.
    Cao TXD; Filliter C; Montastruc F; Yu OHY; Fergusson E; Rej S; Azoulay L; Renoux C
    J Affect Disord; 2022 Dec; 318():231-237. PubMed ID: 36084758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dialysate calcium concentration and the risk of sudden cardiac arrest in hemodialysis patients.
    Pun PH; Horton JR; Middleton JP
    Clin J Am Soc Nephrol; 2013 May; 8(5):797-803. PubMed ID: 23371957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of QT prolongation with serotonin reuptake inhibitors.
    Ojero-Senard A; Benevent J; Bondon-Guitton E; Durrieu G; Chebane L; Araujo M; Montastruc F; Montastruc JL
    Psychopharmacology (Berl); 2017 Oct; 234(20):3075-3081. PubMed ID: 28770276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-Dose Citalopram and Escitalopram and the Risk of Out-of-Hospital Death.
    Ray WA; Chung CP; Murray KT; Hall K; Stein CM
    J Clin Psychiatry; 2017 Feb; 78(2):190-195. PubMed ID: 27736049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A large-scale observational comparison of antidepressants and their effects.
    Heinz MV; Yom-Tov E; Mackin DM; Matsumura R; Jacobson NC
    J Psychiatr Res; 2024 Oct; 178():219-224. PubMed ID: 39163659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low Potassium Dialysate as a Protective Factor of Sudden Cardiac Death in Hemodialysis Patients with Hyperkalemia.
    Huang CW; Lee MJ; Lee PT; Hsu CY; Huang WC; Chen CL; Chou KJ; Fang HC
    PLoS One; 2015; 10(10):e0139886. PubMed ID: 26440515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative safety of selective serotonin reuptake inhibitors among pediatric users with respect to adverse cardiac events.
    Czaja AS; Valuck RJ; Anderson HD
    Pharmacoepidemiol Drug Saf; 2013 Jun; 22(6):607-14. PubMed ID: 23456956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of serum and dialysate electrolytes with QT interval and prolongation in incident hemodialysis: the Predictors of Arrhythmic and Cardiovascular Risk in End-Stage Renal Disease (PACE) study.
    Kim ED; Watt J; Tereshchenko LG; Jaar BG; Sozio SM; Kao WHL; Estrella MM; Parekh RS
    BMC Nephrol; 2019 Apr; 20(1):133. PubMed ID: 30999887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the risk of QT prolongation among SSRIs.
    Funk KA; Bostwick JR
    Ann Pharmacother; 2013 Oct; 47(10):1330-41. PubMed ID: 24259697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic review and guide to selection of selective serotonin reuptake inhibitors.
    Edwards JG; Anderson I
    Drugs; 1999 Apr; 57(4):507-33. PubMed ID: 10235690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortality Risk Among Patients With COVID-19 Prescribed Selective Serotonin Reuptake Inhibitor Antidepressants.
    Oskotsky T; Maric I; Tang A; Oskotsky B; Wong RJ; Aghaeepour N; Sirota M; Stevenson DK
    JAMA Netw Open; 2021 Nov; 4(11):e2133090. PubMed ID: 34779847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis of selective serotonin reuptake inhibitor-associated QTc prolongation.
    Beach SR; Kostis WJ; Celano CM; Januzzi JL; Ruskin JN; Noseworthy PA; Huffman JC
    J Clin Psychiatry; 2014 May; 75(5):e441-9. PubMed ID: 24922496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative cardiovascular safety of selective serotonin reuptake inhibitors (SSRIs) among Chinese senile depression patients: A network meta-analysis of randomized controlled trials.
    Guo S; Chen L; Cheng S; Xu H
    Medicine (Baltimore); 2019 May; 98(22):e15786. PubMed ID: 31145302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of SSRI antidepressants on ejaculation: a double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline.
    Waldinger MD; Hengeveld MW; Zwinderman AH; Olivier B
    J Clin Psychopharmacol; 1998 Aug; 18(4):274-81. PubMed ID: 9690692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential Associations of Specific Selective Serotonin Reuptake Inhibitors With Resting-State Heart Rate and Heart Rate Variability: Implications for Health and Well-Being.
    Kemp AH; Fráguas R; Brunoni AR; Bittencourt MS; Nunes MA; Dantas EM; Andreão RV; Mill JG; Ribeiro AL; Koenig J; Thayer JF; Benseñor IM; Lotufo PA
    Psychosom Med; 2016 Sep; 78(7):810-8. PubMed ID: 27219492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Bayesian net benefit regression model to examine the impact of generic drug entry on the cost effectiveness of selective serotonin reuptake inhibitors in elderly depressed patients.
    Shih YC; Bekele NB; Xu Y
    Pharmacoeconomics; 2007; 25(10):843-62. PubMed ID: 17887806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.